THOMAS LLOYD to Autoantibodies
This is a "connection" page, showing publications THOMAS LLOYD has written about Autoantibodies.
Connection Strength
0.763
-
Characterizing local antibody responses in the muscle of inclusion body myositis patients. J Autoimmun. 2025 Jun; 154:103437.
Score: 0.189
-
Pathological autoantibody internalisation in myositis. Ann Rheum Dis. 2024 10 21; 83(11):1549-1560.
Score: 0.181
-
Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis. Arthritis Rheumatol. 2022 02; 74(2):358-364.
Score: 0.149
-
A Case of Morvan Syndrome Mimicking Amyotrophic Lateral Sclerosis With Frontotemporal Dementia. J Clin Neuromuscul Dis. 2016 Jun; 17(4):207-11.
Score: 0.101
-
Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. Ann Rheum Dis. 2023 08; 82(8):1091-1097.
Score: 0.041
-
Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1? autoantibodies. Ann Rheum Dis. 2023 Feb; 82(2):246-252.
Score: 0.039
-
The phenotype of myositis patients with anti-Ku autoantibodies. Semin Arthritis Rheum. 2021 08; 51(4):728-734.
Score: 0.036
-
More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford). 2017 05 01; 56(5):787-794.
Score: 0.027